144 related articles for article (PubMed ID: 24356627)
1. A cohort study investigating aspirin use and survival in men with prostate cancer.
Flahavan EM; Bennett K; Sharp L; Barron TI
Ann Oncol; 2014 Jan; 25(1):154-9. PubMed ID: 24356627
[TBL] [Abstract][Full Text] [Related]
2. A cohort study of digoxin exposure and mortality in men with prostate cancer.
Flahavan EM; Sharp L; Bennett K; Barron TI
BJU Int; 2014 Feb; 113(2):236-45. PubMed ID: 23937513
[TBL] [Abstract][Full Text] [Related]
3. Low-dose aspirin use and survival in breast cancer patients: A nationwide cohort study.
Mc Menamin ÚC; Cardwell CR; Hughes CM; Murray LJ
Cancer Epidemiol; 2017 Apr; 47():20-27. PubMed ID: 28088656
[TBL] [Abstract][Full Text] [Related]
4. Use of Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis: A Nationwide Cohort Study.
Skriver C; Dehlendorff C; Borre M; Brasso K; Larsen SB; Dalton SO; Nørgaard M; Pottegård A; Hallas J; Sørensen HT; Friis S
Ann Intern Med; 2019 Apr; 170(7):443-452. PubMed ID: 30831581
[TBL] [Abstract][Full Text] [Related]
5. Do Aspirin and Other NSAIDs Confer a Survival Benefit in Men Diagnosed with Prostate Cancer? A Pooled Analysis of NIH-AARP and PLCO Cohorts.
Zhou CK; Daugherty SE; Liao LM; Freedman ND; Abnet CC; Pfeiffer R; Cook MB
Cancer Prev Res (Phila); 2017 Jul; 10(7):410-420. PubMed ID: 28507039
[TBL] [Abstract][Full Text] [Related]
6. The use of aspirin and the risk of mortality in patients with prostate cancer.
Assayag J; Pollak MN; Azoulay L
J Urol; 2015 Apr; 193(4):1220-5. PubMed ID: 25463991
[TBL] [Abstract][Full Text] [Related]
7. Associations of low-dose aspirin or other NSAID use with prostate cancer risk in the Danish Diet, Cancer and Health Study.
Skriver C; Dehlendorff C; Borre M; Brasso K; Larsen SB; Tjønneland A; Pottegård A; Hallas J; Sørensen HT; Friis S
Cancer Causes Control; 2020 Feb; 31(2):139-151. PubMed ID: 31823168
[TBL] [Abstract][Full Text] [Related]
8. Non-Steroidal Anti-Inflammatory Drugs and Cancer Death in the Finnish Prostate Cancer Screening Trial.
Veitonmäki T; Murtola TJ; Talala K; Taari K; Tammela T; Auvinen A
PLoS One; 2016; 11(4):e0153413. PubMed ID: 27100876
[TBL] [Abstract][Full Text] [Related]
9. Use of non-steroidal anti-inflammatory drugs and prostate cancer survival in the Finnish prostate cancer screening trial.
Veitonmäki T; Murtola TJ; Määttänen L; Taari K; Stenman UH; Tammela TL; Auvinen A
Prostate; 2015 Sep; 75(13):1394-402. PubMed ID: 26073992
[TBL] [Abstract][Full Text] [Related]
10. Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.
Platz EA; Rohrmann S; Pearson JD; Corrada MM; Watson DJ; De Marzo AM; Landis PK; Metter EJ; Carter HB
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):390-6. PubMed ID: 15734963
[TBL] [Abstract][Full Text] [Related]
11. Aspirin Use and Lethal Prostate Cancer in the Health Professionals Follow-up Study.
Downer MK; Allard CB; Preston MA; Wilson KM; Kenfield SA; Chan JM; Mucci LA; Giovannucci E; Stampfer MJ
Eur Urol Oncol; 2019 Mar; 2(2):126-134. PubMed ID: 31017087
[TBL] [Abstract][Full Text] [Related]
12. Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians' Health Study.
Downer MK; Allard CB; Preston MA; Gaziano JM; Stampfer MJ; Mucci LA; Batista JL
Eur Urol; 2017 Nov; 72(5):821-827. PubMed ID: 28189429
[TBL] [Abstract][Full Text] [Related]
13. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease.
Grytli HH; Fagerland MW; Fosså SD; Taskén KA
Eur Urol; 2014 Mar; 65(3):635-41. PubMed ID: 23351721
[TBL] [Abstract][Full Text] [Related]
14. Daily aspirin use and prostate cancer-specific mortality in a large cohort of men with nonmetastatic prostate cancer.
Jacobs EJ; Newton CC; Stevens VL; Campbell PT; Freedland SJ; Gapstur SM
J Clin Oncol; 2014 Nov; 32(33):3716-22. PubMed ID: 25332245
[TBL] [Abstract][Full Text] [Related]
15. Prediagnostic aspirin use and mortality in women with stage I to III breast cancer: A cohort study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Bradley MC; Black A; Freedman AN; Barron TI
Cancer; 2016 Jul; 122(13):2067-75. PubMed ID: 27149646
[TBL] [Abstract][Full Text] [Related]
16. De Novo Post-Diagnosis Aspirin Use and Mortality in Women with Stage I-III Breast Cancer.
Barron TI; Murphy LM; Brown C; Bennett K; Visvanathan K; Sharp L
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):898-904. PubMed ID: 25791705
[TBL] [Abstract][Full Text] [Related]
17. Aspirin and Non-Aspirin NSAID Use and Prostate Cancer Incidence, Mortality, and Case Fatality in the Atherosclerosis Risk in Communities Study.
Hurwitz LM; Joshu CE; Barber JR; Prizment AE; Vitolins MZ; Jones MR; Folsom AR; Han M; Platz EA
Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):563-569. PubMed ID: 30487131
[TBL] [Abstract][Full Text] [Related]
18. Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality.
Bardia A; Ebbert JO; Vierkant RA; Limburg PJ; Anderson K; Wang AH; Olson JE; Vachon CM; Cerhan JR
J Natl Cancer Inst; 2007 Jun; 99(11):881-9. PubMed ID: 17551148
[TBL] [Abstract][Full Text] [Related]
19. Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer.
Murtola TJ; Peltomaa AI; Talala K; Määttänen L; Taari K; Tammela TLJ; Auvinen A
Eur Urol Focus; 2017 Apr; 3(2-3):212-220. PubMed ID: 28753762
[TBL] [Abstract][Full Text] [Related]
20. Clopidogrel use and cancer-specific mortality: a population-based cohort study of colorectal, breast and prostate cancer patients.
Hicks BM; Murray LJ; Hughes C; Cardwell CR
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):830-40. PubMed ID: 26017274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
